MedTrace Logo

Trichoscopic Predictors of Treatment Response in Tinea Capitis: A Prospective Study

NCT07043582 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-06-29

No results posted yet for this study

Summary

Brief Summary (Plain Language Version)

The goal of this observational study is to learn how well changes seen under a special microscope called a trichoscope (used to look at hair and scalp) match the success of treatment in children and adolescents with a scalp fungal infection called tinea capitis. The main questions it aims to answer are:

Do changes in trichoscopic findings show when the fungal infection is cured?

Does having more severe trichoscopic findings at the start mean that treatment will take longer or be less successful?

Do different fungus types respond differently to the same treatment?

Participants will:

Be between the ages of 0 and 18 with confirmed tinea capitis based on lab tests (microscopy and/or culture)

Receive an oral antifungal medicine called terbinafine for 4 weeks (dosing based on weight)

Attend regular checkups every 4 weeks until both scalp appearance and lab tests show the infection is gone

At each visit, participants will:

Have their scalp examined using a trichoscope

Provide scalp samples for fungal testing

Be assessed for symptoms like itching, redness, and scaling

The study will also look at how fast different signs on the scalp go away, and which of these signs are best at predicting whether the fungus is still present.

Conditions

  • Tinea Capitis

Sponsors & Collaborators

  • Istanbul Medeniyet University

    lead OTHER

Principal Investigators

  • Vefa Aslı Erdemir, Proffesor · medeniyet university

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-24
Primary Completion
2025-09-10
Completion
2025-10-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07043582 on ClinicalTrials.gov